Murielle Roussel^1,2*, Nathalie Texier^3*, Raphaël Germain, MSc^3*, Sandhya Sapra, PhD^4*, Prani Paka, PharmD^4*, Naima Kerbouche, MD^5*, Xavier Colin, MSc^5* and Xavier Leleu, MD, PhD^6,7

¹CHU Dupuytren, Hématologie clinique et thérapie cellulaire, Limoges, France
²CRIBL Lab, CNRS UMR7276 INSERM U1262, Limoges, France
³Kappa Santé, Paris, France
⁴GSK, Upper Providence, PA
⁵GSK, Rueil-Malmaison, France
⁶Département d’hématologie, Centre Hospitalier Universitaire, Université de Poitiers, Poitiers, France
⁷INSERM CIC-1042, Poitiers University Hospital, Poitiers, France

Hang Quach¹, Sung-Soo Yoon, MD, PhD², Kihyun Kim, MD³, Ji Hyun Lee, MD, PhD⁴, Chandramouli Nagarajan, MBBS^5*, Phoebe Joy Ho, MBBS(Syd) DPhil(Oxon) FRACP FRCPA FFSc(RCPA)^6*, Michael S.Y. Low, MBBS, PhD, FRACP, FRCPA^7*, Wei-Han Huang^8*, Raymond Wong, MBChB, MD⁹, Nina Liao^10*, ChingFeng Lin^10*, Matthew Britland, PhD^11*, Julia Li^12*, Stella Chai^12* and Jin Seok Kim, MD, PhD^13*

¹University of Melbourne, St. Vincent’s Hospital, Melbourne, VIC, Australia
²Seoul National University Hospital, Seoul, Korea, Republic of (South)
³Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan Univ. Sch. of Med. Samsung Medical Center, Seoul, Korea, Republic of (South)
⁴Department of Internal Medicine, Dong-A University College of Medicine, Busan, South Korea
⁵SingHealth Duke-NUS Blood Cancer Center and Singapore General Hospital, Singapore, Singapore
⁶Royal Prince Alfred Hospital and University of Sydney, Camperdown, Sydney, NSW, Australia
⁷Monash Medical Centre, Melbourne, Australia
⁸Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien City, Taiwan
⁹Sir YK Pao Centre for Cancer & Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, Hong Kong
¹⁰Parexel International, Taipei, Taiwan
¹¹Amgen Australia Pty Limited, Dulwich Hill, NSW, Australia
¹²Amgen Asia Holding Limited, Quarry Bay, Hong Kong
¹³Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea, Republic of (South)

Julie Barberio^1,2*, Timothy L. Lash, DSc, MPH^2*, Ajay K. Nooka, MD, MPH, FACP³, Ashley I. Naimi, PhD^2*, Rachel E. Patzer, PhD, MPH^2* and Christopher Kim, PhD, MPH¹

¹Center for Observational Research, Amgen Inc., Thousand Oaks, CA
²Department of Epidemiology, Emory University, Atlanta, GA
³Winship Cancer Institute of Emory University, Atlanta, GA

Noemi Puig, MD, PhD^1*, Vania T. M. Hungria, MD, PhD², Ajai Chari^3*, Faith E. Davies, MD^4*, Gordon Cook^5*, Roman Hájek, MD, PhD⁶, Kathryn E. Morgan, MSc^7*, Jim Omel, MD^8*, Evangelos Terpos, MD, PhD⁹, Michael A. Thompson^10,11*, Saad Usmani, MD¹², Jorge Vela-Ojeda, MD, PhD^13*, Katja C. Weisel, MD^14,15, Mira Armour, BSc^16*, Kaili Ren, PhD^17*, Dasha Cherepanov, PhD^17*, Dawn Marie Stull, Pharm.D., BCOP^18* and Jesus Berdeja, MD¹⁹

¹Hospital Universitario de Salamanca Hematología, Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain
²Clinica São Germano and Santa Casa Medical School, São Paulo, Brazil
³Hematology and Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
⁴Perlmutter Cancer Center, NYU Langone, New York, NY
⁵Leeds Cancer Centre, Leeds Teaching Hospitals Trust, Leeds, United Kingdom
⁶Department of Hemato-oncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic
⁷Myeloma Patients Europe, Brussels, Belgium
⁸The Central Nebraska Myeloma Support Group, Grand Island, NE
⁹Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
¹⁰Tempus Labs, Chicago, IL
¹¹Aurora Cancer Care, Advocate Aurora Health, Milwaukee, WI
¹²Levine Cancer Institute, Charlotte, NC
¹³Department of Medicine, Division of Blood and Marrow Transplantation, Moores UMAE Especialidades Centro Medico La Raza IMSS, Ciudad de México, Mexico
¹⁴Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
¹⁵University Medical Center Hamburg-Eppendorf, Hamburg, Germany
¹⁶Mijelom CRO, Croatian Myeloma Support Association, Zagreb, Croatia
¹⁷Takeda Development Center Americas, Inc. (TDCA), Lexington, MA
¹⁸Takeda Pharmaceuticals U.S.A., Inc., Lexington, MA
¹⁹Tennessee Oncology and Sarah Cannon Research Institute, Nashville

Xiang Zhou^1*, Annika Hofmann^2*, Cornelia Vogt, MSc^3*, Silvia Nerreter^3*, Eva Teufel, MSc^3*, Emilia Stanojkovska^4*, Marietta Truger^5*, Benedict Engel^2*, Anastasia Barcic^6*, Jessica Peter, MD^6*, Christine Riedhammer^6*, Max Johannes Steinhardt^3*, Xianghui Xiao^6*, Hannah Hornburger, MD^6*, Seungbin Han, MSc^3*, Larissa Haertle^7*, Umair Munawar, PhD^3*, Julia Mersi, MD^3*, Claudia Haferlach, MD⁸, Hermann Einsele, MD⁹, Leo Rasche, MD^10* and K. Martin Kortuem^11*

¹Department of Internal Medicine II, University Hospital Wuerzburg, WüRzburg, Germany
²University of Würzburg, Würzburg, Germany
³Department of Internal Medicine II, University Hospital Wuerzburg, Wuerzburg, Germany
⁴Mildred Scheel Early Career Center (MSNZ), University Hospital Würzburg, Würzburg, DEU
⁵MLL Munich Leukemia Laboratory, Inning am Ammersee, Germany
⁶University Hospital Würzburg, Würzburg, Germany
⁷H12O-CNIO Hematological Malignancies Group, Clinical Research Unit. CNIO, Madrid, Spain
⁸MLL Munich Leukemia Laboratory, Munich, Germany
⁹Universitaetsklinikum Wuerzburg, Med. Klinik und Poliklinik II, Wuerzburg, Germany
¹⁰Department of Internal Medicine II, University Hospital Wuerzburg, Wuerzburg, Bayern, Germany
¹¹Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany

Foteini Theodorakakou, MD^1*, Vasiliki Spiliopoulou, MD^2*, Despina Fotiou, MD^1*, Maria Roussou, MD^2*, Panagiotis Malandrakis, MD^1*, Ioannis Ntanasis-Stathopoulos, MD^2*, Magdalini Migkou, MD^1*, Evangelos Eleutherakis Papaiakovou, MD^2*, Nikolaos Kanellias, MD^2*, Asimina Papanikolaou, MD^3*, Maria Gavriatopoulou, MD^1*, Evangelos Terpos, MD, PhD², Meletios-Athanasios Dimopoulos, MD, PhD¹ and Efstathios Kastritis, MD^2*

¹Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
²Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
³Department of Hemopathology, "Evangelismos" General Hospital, Athens, Greece

Aytaj Mammadzadeh^1*, Fulei Peng, MD^2*, Shebli Atrash, MD^3,4, Hamza Hashmi, MD^3,5, Meera Mohan, MD^3,6, Omar Alkharabsheh, MBBS^3,7, Aimaz Afrough, MD^3,8, Wei Cui, MD^3,9*, Zahra Mahmoudjafari, PhD^3,10* and Al-Ola Abdallah, MD^11,12

¹Division of Hematology, Mayo Clinic, Rochester, MN
²Department of Internal Medicine, Mercy St. Louis Hospital, St. Louis, MO
³US Myeloma Research Innovations Research Collaborative (USMIRC), Westwood, KS
⁴Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC
⁵Department of Hematology/Medical Oncology, Medical University of South Carolina, Charleston, SC
⁶Medical College of Wisconsin, Milwaukee, WI
⁷Division of Hematology/Oncology, University of South Alabama Mitchell Cancer Institute, Mobile, AL
⁸Division of Hematologic Malignancies and Cellular Therapy, Dept of Internal Medicine, Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
⁹University of Kansas Medical Center, Kansas City, KS
¹⁰Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
¹¹Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS
¹²US Myeloma Innovations Research Collaborative (USMIRC), Westwood, KS

Efstathios Kastritis, MD^1*, Foteini Theodorakakou, MD^2*, Despina Fotiou, MD^2*, Ioannis Ntanasis-Stathopoulos, MD^2*, Vasiliki Spiliopoulou, MD^3*, Panagiotis Malandrakis, MD^2*, Magdalini Migkou, MD^2*, Evangelos Eleutherakis Papaiakovou, MD^3*, Nikolaos Kanellias, MD^4*, Maria Gavriatopoulou, MD^2*, Evangelos Terpos, MD, PhD³ and Meletios A. Dimopoulos, MD³

¹Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, ATHENS, Greece
²Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
³Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
⁴Department of Therapeutics, National and Kapodistrian University of Athens, Alexandra Hospital, Athens, Greece

Mohamed A Badawi, PhD^1*, Sheryl Coppola, PhD^1*, Doerthe Eckert, MSc^2*, Sathej Gopalakrishnan, PhD^2*, Eva Doelger^2*, Edyta Dobkowska, MD^3*, Shaji K Kumar, MD⁴, Weize Huang, PhD^5*, Rajeev Menon, PhD^1* and Ahmed Hamed Salem, PhD, FCP¹

¹Clinical Pharmacology, AbbVie Inc., North Chicago, IL
²Clinical Pharmacology, AbbVie Deutschland GmbH & Co. KG, Ludwigshafen am Rhein, Germany
³Pharmacyclics Switzerland GmbH, An AbbVie Company, Schaffhausen, Switzerland
⁴Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
⁵Clinical Pharmacology, Genentech Inc, South San Francisco, CA

Lawrence Liu, MD^1*, Nikhil Grandhi^2*, Mei Wang^3*, Theodore S. Thomas, MD, MPHS⁴, Akhil Kumar^3*, Kristin Vargo^3*, Kristen M. Sanfilippo, MD⁵, Graham A Colditz, MD, DrPH^6* and Su-Hsin Chang, PhD^7*

¹City of Hope National Medical Center, Duarte, CA
²Washington University in St. Louis, Saint Louis, MO
³Research Service, St. Louis Veterans Affairs Medical Center, St. Louis, MO
⁴St. Louis Veterans Affairs Medical Center, Saint Louis, MO
⁵Division of Hematology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO
⁶Division of Public Health Sciences, Department of Surgery, Washington University in St. Louis School of Medicine, St Louis, MO
⁷Research Service, St. Louis Veterans Affairs Medical Center, Saint Louis, MO

Natasha S Bahri, MD^1*, Alfred Chung, MD², Chiung-Yu Huang, PhD^3*, Shagun Arora, MD², Jeffrey L. Wolf, MD², Thomas Martin, MD², Nina Shah, MD⁴, Moming Li, PhD^5* and Sandy W. Wong, MD²

¹Department of Medicine, University of California San Francisco, San Francisco, CA
²Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA
³Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA
⁴Division of Hematology and Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA
⁵Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA

Alissa Visram, MD¹, Alfredo De La Torre, MD^2*, Darrell White, MD^3*, Moustafa Kardjadj, PhD^4*, Esther Masih-Khan, PhD^5,6*, Michael P. Chu^7*, Victor H Jimenez-Zepeda, MD⁸, Arleigh McCurdy, MD, BSc⁹, Richard Leblanc, MD, FRCPC¹⁰, Kevin Song, MD, FRCPC¹¹, Hira S Mian, MD¹², Martha L Louzada, MD, MSc¹³, Michael Sebag, MD, PhD¹⁴, Debra Bergstrom^15*, Julie Stakiw, MD, FRCPC¹⁶, Anthony Reiman, MD^17*, Rami Kotb, MD, FRCPC¹⁸, Muhammad Aslam, MD^19*, Christopher P. Venner, MD, FRCPC²⁰, Rayan Kaedbey, MD²¹, Engin Gul, BSc, MBA^22* and Donna E. Reece, MD, FRCPC^23,24

¹Department of Medicine, University of Ottawa, The Ottawa Hospital Research Institute, Ottawa, ON, Canada
²Queen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, NS, Canada
³Division of Hematology, Dalhousie University and Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada
⁴Canadian Myeloma Research Group, Toronto, ON, Canada
⁵Canadian Myeloma Research Group (formerly MCRN), Toronto, Canada
⁶Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
⁷Department of Oncology, Cross Cancer Institute, Edmonton, Alberta, Edmonton, AB, Canada
⁸Tom Baker Cancer Center, Department of Hematology, University of Calgary, Calgary, AB, Canada
⁹Department of Medicine, Division of Hematology, The Ottawa Hospital, Ottawa, ON, Canada
¹⁰Hopital Maisonneuve-Rosemont, Hopital Maisonneuve-Rosemont, Montreal, QC, Canada
¹¹The Leukemia/Bone Marrow Transplant Program of BC, British Columbia Cancer Agency, Vancouver, Canada
¹²Juravinski Cancer Centre (Hamilton-CCO), Hamilton, ON, Canada
¹³University of Western Ontario, London Health Sciences Centre, London, ON, Canada
¹⁴Division of Hematology, McGill University Health Centre, Montreal, QC, Canada
¹⁵Division of Hematology, Memorial University of Newfoundland, St John’s, Newfoundland and Labrador, Canada, St John's, NF, Canada
¹⁶Saskatoon Cancer Centre, Saskatoon, SK, Canada
¹⁷Oncology, Saint John Regional Hospital, Saint John, NB, CAN
¹⁸Department of Medical Oncology and Hematology, CancerCare Manitoba, Winnipeg, MB, Canada
¹⁹Allan Blair Cancer Center, Regina, SK, Canada
²⁰BC Cancer Centre for Lymphoid Cancer and The University of British Columbia, Vancouver, BC, Canada
²¹Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Montreal, QC, Canada
²²Canadian Myeloma Research Group (CMRG), Concord, ON, Canada
²³Canadian Myeloma Research Group (CMRG), Vaughan, ON, Canada
²⁴Princess Margaret Cancer Centre, Toronto, ON, Canada

Lauren M Granat, DO, MS^1*, Hong Li, MS^2*, Faiz Anwer, MD^3*, Michael Sheu, MD^1*, Beth M. Faiman, PhD, CNP³, Jack Khouri, MD³, Sandra Mazzoni, DO^4*, Jason Valent, MD³, Christy J. Samaras, DO³, Rajshekar Chakraborty, MD⁵, Chakra P Chaulagain, MD, FACP⁶, Willem J. van Heeckeren, MD, PhD³ and Louis S. Williams, MD³

¹Department of Internal Medicine, Cleveland Clinic, Cleveland, OH
²Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH
³Department of Hematology and Medical Oncology, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH
⁴Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic Foundation, Cleveland, OH
⁵Hematology and Medical Oncology, Columbia University, Irving Medical Center, New York, NY
⁶Department of Hematology and Oncology, Cleveland Clinic Florida, Maroone Cancer Center, Weston, FL

Harshini Sriram, M.Sc.^1,2*, Twinkle Khanka, M.Sc.^1,2*, Sanghamitra Gawai, BSc^1,2*, Sitaram Ghogale, BSc^1,2*, Nilesh Deshpande, BSc^1,2*, Shipra Sharma^3*, Sanchi Shah^3*, Anirvan Chatterjee^3*, Gaurav Chatterjee, MD^1,2*, Sweta Rajpal, MD, DM^1,2*, Nikhil Patkar, MD^1,2*, Syed Khizer Hasan, PhD^2,4*, Bhausaheb Bagal, MD, DM^2,5*, Hasmukh Jain, MD, DM^2,5*, Dhanlaxmi Lalit Shetty, PhD^2,6*, Nitin Inamdar, PhD^2,7*, Sachin Punatar, MD, DM^2,5*, Anant Gokarn, MD, DM^2,5*, Manju Sengar, MD, DM ^2,5, Navin Khattry, MD, DM^8,9*, Papagudi Ganesan Subramanian, MD^2,10*, Sumeet Gujral, MD^2,11* and Prashant R. Tembhare, MD^1,2

¹Hematopathology Laboratory, ACTREC, Tata Memorial Centre, Navi Mumbai, India
²Homi Bhabha National Institute, Mumbai, India
³HaystackAnalytics Pvt. Ltd., Mumbai, India
⁴ACTREC, Tata Memorial Centre, Navi Mumbai, India
⁵Department of Medical Oncology, Tata Memorial Centre, Mumbai, India
⁶Adult Hematolymphoid Disease Management Group, Department of Medical Oncology, ACTREC, Tata Memorial Centre, Navi Mumbai, Maharashtra, IND
⁷Department of Biochemistry, Tata Memorial Centre, India, Mumbai, India
⁸Department of Bone Marrow Transplant, ACTREC, Tata Memorial Centre, Navi Mumbai, India
⁹Homi Bhabha National Institute, India, Mumbai, India
¹⁰Hematopathology Laboratory, ACTREC, Tata Memorial Centre, Navi Mumbai, Maharashtra, India
¹¹Hematopathology Laboratory, Tata Memorial Centre, Mumbai, India

Kevin D. Arnold, MPH^1*, Krystle L. Ong, PhD¹, Hannah P. Cutshall, MD^2* and Elizabeth E. Brown, PhD, MPH^1,3

¹Department of Pathology, University of Alabama at Birmingham, Birmingham, AL
²University of Arkansas for Medical Sciences, Little Rock, AR
³University of Alabama at Birmingham, O’Neal Comprehensive Cancer Center, Birmingham, AL

Jacob Edmisson, MD^1*, Mark A Fiala, PhD^2*, Michael J Slade, MD, MS², Angela Vickroy, ANP^3*, Margaret Kavanaugh, ANP^3*, Carmen Wilson, MPAS^4*, Jingyu Xiang, MD, MSci^5*, Zachary D. Crees, MD⁶, Mark A. Schroeder, MD³, Keith E Stockerl-Goldstein, MD², John F. DiPersio, MD, PhD⁷ and Ravi Vij, MD⁸

¹Washington University School of Medicine, Saint Louis, MO
²Department of Medicine, Division of Hematology & Oncology, Washington University School of Medicine, St. Louis, MO
³Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO
⁴Division of Bone Marrow Transplant, Washington University School of Medicine, Saint Louis
⁵Department of Oncology, Washington University School of Medicine, Saint Louis, MO
⁶Division of Oncology, Washington University School of Medicine, St. Louis, MO
⁷Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, Saint Louis, MO
⁸Division of Oncology, Washington University School of Medicine, Saint Louis, MO

Nathanael R Fillmore, PhD^1,2,3*, Jennifer La, PhD^4*, Julie Tsu-Yu Wu, MD, PhD^5,6*, Westyn Branch-Elliman, MD^3,7*, Paul Monach, MD^3,7*, Mary Brophy, MD, MPH^8,9*, Nhan V Do, MD^9,10* and Nikhil C Munshi, MD, PhD^3,11,12

¹CSP Informatics Center, MAVERIC, VA Boston Healthcare System, Cambridge, MA
²Dana-Farber Cancer Institute, Boston, MA
³Harvard Medical School, Boston, MA
⁴CSP Informatics Center, MAVERIC, VA Boston Healthcare System, Boston, MA
⁵Stanford University, Palo Alto, CA
⁶VA Palo Alto Healthcare System, Palo Alto, CA
⁷VA Boston Healthcare System, Boston, MA
⁸Department of Medicine, Section of Hematology and Medical Oncology, Boston University School of Medicine, Boston Medical Center, Boston, MA
⁹Department of Medicine, VA Boston Healthcare System, Boston, MA
¹⁰Boston University School of Medicine, Boston, MA
¹¹Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston, MA
¹²VA Boston Healthcare System, Boston

Benjamin Dimbleby^1*, Tatiana Zhelezniakova^2*, Alex G Richter, MD^3*, Charlotte Pawlyn, PhD⁴, John R Jones, MD^5*, Matthew W Jenner^6*, David Cairns, PhD^7*, Tom Menzies^8*, Walter Martin Gregory, PhD^8*, Martin F. Kaiser, MD, FRCP, FRCPath⁹, Gordon Cook, MB ChB, PhD, FRCP(Glas), FRCPath^8*, Roger G Owen^10*, Graham Jackson, MBBS, FRCP, FRCPath, MA, DM¹¹, Faith E Davies, MD¹², Gareth J. Morgan, MD¹³ and Mark T Drayson, MD^3*

¹University of Birmingham Medical School, Birmingham, ENG, United Kingdom
²NHS Highland, Inverness, United Kingdom
³Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom
⁴Institute of Cancer Research, Sutton, United Kingdom
⁵Institute of cancer research, London, United Kingdom
⁶Department of Haematology, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom
⁷Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, ENG, United Kingdom
⁸Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom
⁹The Institute of Cancer Research, London, ENG, United Kingdom
¹⁰St. James's University Hospital, Leeds, United Kingdom
¹¹Department of Haematology, NCCC Freeman Road Hospital, Newcastle Upon Tyne, United Kingdom
¹²Myeloma Center, Division of Hematology/Oncology, Winthrop P. Rockefeller Cancer Institute, University of Arkansas, New York, NY
¹³Myeloma Research Program, Perlmutter Cancer Center, NYU Langone Health, New York, NY

Shambavi Richard, MD^1,2,3,4, Guido Lancman, MD, MSc³, Adriana Rossi, MD, MSc⁵, Ajai Chari, MD⁶, Samir Parekh, MD³, Larysa Sanchez, MD^4*, Cesar Rodriguez, MD⁴, Hearn J. Cho, MD, PhD⁴, Joshua Richter, MD⁴, Santiago Thibaud, MD⁴, Kiah Purcell, NP^7*, Elizabeth Aronson, NP^8*, Daniel Verina, ANP^2*, Juliet Escalon, NP^8*, Karen Louw, NP^7* and Sundar Jagannath⁹

¹Tisch Cancer Institute, Mount Sinai Health System, Bronx, NY
²Mount Sinai Medical Center, New York, NY
³Department of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
⁴Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
⁵Icahn School of Medicine, Mount Sinai Hospital, New York, NY
⁶Department of Hematology and Medical Oncology, Tisch Cancer Institute, Mount Sinai School of Medicine, New York, NY
⁷Mount Sinai School of Medicine, New York, NY
⁸Mount Sinai Hospital, New York, NY
⁹Department of Medicine, Hematology and Medical Oncology, Mount Sinai Medical Center, New York, NY

Elizabeth D. Lightbody, PhD^1,2,3, Hasmik Keshishian, PhD^3*, Habib El-Khoury, MD^1,2, Ankit K. Dutta, PhD^1,2,3*, Hadley Barr, BA^1,2*, Jes Barbagallo, PhD^4*, Namrata Udeshi, PhD^3*, Michael P. Agius, PhD^1,2,3*, Nang Kham Su, MS^2*, Cody J. Boehner, BS^1,2*, Laura Hevenor, BS^2*, Katherine Towle, BS^2*, Christian J. Cea-Curry, BS^1,2*, Jacqueline Perry, MPH^1,2*, Erica Horowitz, BA^2*, Maya I. Davis, BA^1,2*, Anna Cowan, BA^2*, Evan Mills, MS^4*, Marijana Rucevic, PhD^4*, DR Mani, PhD^3*, Daniel Auclair, PhD⁵, Catherine R. Marinac, PhD^2,6, Michael A Gillette^3*, Steven A Carr, PhD^3* and Irene Ghobrial, MD^1,2,3

¹Department of Medicine, Harvard Medical School, Boston, MA
²Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
³Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA
⁴Olink Proteomics, Waltham, MA
⁵Hematology R&D, AstraZeneca, Waltham, MA
⁶Harvard T.H. Chan School of Public Health, Boston, MA

James Ignatz-Hoover, MD, PhD¹, E Ricky Chan, PhD^2*, Ehsan Malek, MD¹ and James J. Driscoll, MD, PhD^1,3

¹Adult Hematologic Malignancies & Stem Cell Transplant Section, University Hospitals Seidman Cancer Center, Cleveland, OH
²Institute of Computational Biology, Case Western Reserve University School of Medicine, Cleveland, OH
³Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH

Bart Przychodzen^*, Michael Mohrman^*, Jennifer Brzezynski^*, Sophia Truslow^*, Christos Polymeropoulos^* and Mihales Polymeropoulos^*

Vanda Pharmaceuticals, Washington, DC

Larysa Sanchez, MD¹, Mu Cheng, MPH^2*, Dasha Cherepanov, PhD^3*, Maral DerSarkissian, PhD^2*, Dawn Marie Stull, Pharm.D., BCOP^4*, Fei Huang, MPH, PhD^4*, Annalise Hilts, BA^2*, Justin Chun, MHS^2*, Mei Sheng Duh, ScD, MPH² and Sikander Ailawadhi⁵

¹Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
²Analysis Group, Inc., Boston, MA
³Takeda Development Center Americas, Inc. (TDCA), Lexington, MA
⁴Takeda Development Center Americas, Inc., Lexington, MA
⁵Mayo Clinic, Jacksonville, FL

Yuki Otani, MD, PhD^1*, Dean Bottino, PhD^2*, Neeraj Gupta^3*, Majid Vakilynejad, PhD^4* and Yusuke Tanigawara, PhD^5*

¹Department of Anesthesiology and Perioperative Medicine, University of Pittsburgh, Pittsburgh, PA
²Takeda Development Center Americas Inc. (TDCA), Lexington, MA
³Takeda Development Center Americas, Inc. (TDCA), Lexington, MA
⁴Takeda Deveopment Center Americas Inc. (TDCA), Lexington, MA
⁵Keio Frontier Research & Education Collaborative Square (K-FRECS), Tokyo, Japan

Laure Vincent, MD^1*, Anne Charvet-Rumpler, MD^2*, Lotfi Benboubker, MD^3*, Claire Calmettes, MD^4*, Anne-Marie Stoppa, MD^5*, Kamel Laribi, MD^6*, Lauriane Clement Filliatre, MD^7*, Fressia Honeyman, MD^8*, Richez Valentine, MD^9*, Cyrille Hulin^10*, Frédéric Maloisel, MD^11*, Margaret Macro, MD^12*, Lionel Karlin^13*, Vanessa Barué, MD^14*, Christos Chouaid, MD, PhD^15*, Hacène Zerazhi, MD^16* and Xavier Leleu, MD, PhD¹⁷

¹Department of Hematology, Montpellier University Hospital, Montpellier, France
²Hématologie, CHRU Jean Minjoz Besançon, Besancon, France
³Hématologie Thérapie Cellulaire, Hopital Bretonneau, CHRU Tours, Tours, France
⁴Oncologie-Hématologie, Centre Hospitalier de Périgueux, Périgueux, France
⁵Hématologie, Institut Paoli Calmettes, Marseille, France
⁶Hématologie clinique, CH Le Mans, Le Mans, France
⁷Hématologie clinique, Clinique louis pasteur, Essey-lès-Nancy, FRA
⁸Hématologie, C.H.U de Saint-Étienne, Saint-Priest-en-Jarez, France
⁹Hématologie clinique, Hôpital l'Archet, Nice, France
¹⁰Hôpital Haut Leveque, University Hospital, Pessac, France
¹¹Hématologie, Clinique Sainte Anne, Strasbourg, France
¹²Hématologie clinique, IBHN - CHU de Caen, Caen, France
¹³Hématologie clinique, Hospices Civils de Lyon, Lyon, France
¹⁴Takeda France, Paris, France
¹⁵CHI de Créteil, Créteil, France
¹⁶Service Oncologie médicale et Hématologie Clinique, Centre Hospitalier d'Avignon, Avignon, France
¹⁷Department of Oncology, Hematology and Cellular Therapy, Poitiers University Hospital, Poitiers, France

Javier De La Rubia, MD, PhD^1*, Rafael Alonso^2*, Maria Esther Clavero Sanchez^3*, Elham Askari, MD^4*, Alfonso García de Coca, MD, PhD^5*, Ana Maldonado, MD^6*, Margarita Fernandez De La Mata^7*, Fernando Escalante, MD^8,9*, Ana Garcia-Feria^10,11*, Rafael Rios, MD, PhD^12*, Venancio Conesa^13*, Maria Aranzazu Bermudez^14*, Beatriz Merchan^15*, Alberto Velasco, MD^16*, María Jesús Blanchard, MD^17*, Antonia Sampol, MD^18,19, Eukene Gainza González, MD^20*, Pedro M Hernandez^21*, Veronica Gonzalez-Calle, MD, PhD^22,23* and Adrian Alegre, MD, PhD^24,25

¹Hematology Department, Hospital Universitari i Politècnic La Fe, Catholic University of Valencia, Valencia, Spain
²Hematology, Hospital Doce de Octubre, Madrid, Spain
³Hematology, Hospital Virgen de las Nieves, Granada, ESP
⁴Department of Hematology, Fundacion Jimenez Diaz University Hospital, Madrid, Spain
⁵Servicio de Hematología, Hospital Clínico, Valladolid, Spain
⁶Hospital Morales Meseguer, IMIB-Arrixaca, Universidad de Murcia, Murcia, Spain
⁷Hospital Reina Sofia, Córdoba, Spain
⁸Hematology Department, Hospital Universitario de León, León, Spain
⁹Hospital Universitario de León, León, Spain
¹⁰Hematology, Hospital Dr. Peset, Valencia, Spain
¹¹Hematology, HOSPITAL Dr. PESET, Valencia, Valencia, ESP
¹²Hospital Universitario Puerta de Hierro, Madrid, Spain
¹³HGU de Elche, Alicante, Spain
¹⁴Hospital Universitario Marques De Valdecilla, Santander, ESP
¹⁵Hospital U. de Guadalajara, Guadalajara, Spain
¹⁶Hematology, Hospital Rey Juan Carlos, Móstoles, Spain
¹⁷Hematology Service, Hospital Universitario Ramón y Cajal, Madrid, Spain
¹⁸Hospital Universitario Son Espases, Palma De Mallorca, ESP
¹⁹Department of Hematology, Hospital Universitari Son Espases, IdISBa, Palma de Mallorca, Spain
²⁰Hospital Universitario de Galdakao - Usansolo / Servicio de Hematología y Hemoterapia, Osakidetza - Servicio Vasco de Salud, Galdakao, Spain
²¹Hematology, Hospital U San Pedro, Logroño, Spain
²²Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), Centro de Investigación del Cancer (IBMCC-USAL, CSIC), Salamanca, Spain
²³Departamento De Hematología, Hospital Universitario De Salamanca (HUSAL),, Salamanca, ESP
²⁴Hospital Universitario La Princesa, Madrid, Spain
²⁵Univeritary Hospital La Princesa, Madrid, Madrid, Spain

Larissa Haertle^1,2*, Hipolito Nicolas Cuesta Hernandez^3*, Natalia Sofia Buenache^4*, Michal Simicek^5,6*, Renata Snaurova^5,6*, Inmaculada Rapado^4*, Nerea Martinez^7,8*, Nieves López-Muñoz^4*, Jose Maria Sanchez-Pina^4*, Rafael Colmenares^4*, Margarita Sanchez-Beato^7,9*, Miguel Angel Piris^7,10*, Ivan Plaza Menacho^3*, Mehmet Kemal Samur^11,12*, Nikhil C Munshi, MD, PhD¹³, Rosa Ayala^14,15*, K. Martin Kortuem^16*, Santiago Barrio, PhD^1,17* and Joaquin Martinez-Lopez, MD, PhD^4,14*

¹H12O-CNIO Hematological Malignancies Group, Clinical Research Unit. CNIO, Madrid, Spain
²Department of Internal Medicine II, Department of Internal Medicine II, University Hospital WüRzburg, W, WüRzburg, Germany
³Kinases, Protein Phosphorylation and Cancer, Structural Biology Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain
⁴Department of Hematology, Hospital Universitario 12 de Octubre, Spanish National Cancer Research Center (CNIO), Complutense University Madrid, Madrid, Spain
⁵Haematology, Ostrava University Hospital, Ostrava, Czech Republic
⁶Faculty of Medizine, Ostrava University, Ostrava, Czech Republic
⁷Centro de Investigación Biomédica en Red (CIBER) de Cáncer (CIBERONC), Madrid, Spain
⁸Departamento Hematopatología Translacional, IDIVAL, Instituto de Investigación Marqués de Valdecilla, Santander, Spain
⁹Medical Oncology Department, Lymphoma Research Group, Hospital Universitario Puerta de Hierro-Majadahonda, IDIPHISA, Madrid, Spain
¹⁰Pathology Department, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Madrid, Spain
¹¹Department of Data Science, Dana Farber Cancer Institute, Boston, MA
¹²Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA
¹³Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston, MA
¹⁴Altum Sequencing Co., Madrid, Spain
¹⁵Haematological Malignancies Clinical Research Unit, Hospital 12 de Octubre Universidad Complutense, CNIO, CIBERONC, Madrid, Spain
¹⁶Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany
¹⁷Altum sequencing Co., Madrid, Spain

Binod Dhakal, MBBS¹, Hermann Einsele, MD², Jordan M Schecter³, Tito Roccia^4*, William Deraedt^5*, Nikoletta Lendvai^3*, Ana Slaughter^6*, Carolina Lonardi^7*, Kaitlyn Connors^3*, Keqin Qi^8*, Anil Londhe^8*, Robin Carson⁹, Jennifer Voelker^10*, Patricia Cost^4*, Satish Valluri^4*, Erika Florendo^11*, Lida Pacaud^11* and Kwee Yong^12*

¹Medical College of Wisconsin, Milwaukee, WI
²University Hospital of Würzburg, Würzburg, Germany
³Janssen Research & Development, Raritan, NJ
⁴Janssen Global Services, Raritan, NJ
⁵Janssen Research & Development, Beerse, Belgium
⁶Cilag GmbH International, Zug, Switzerland
⁷Janssen, Buenos Aires, AL, Argentina
⁸Janssen Research & Development, Titusville, NJ
⁹Janssen Research & Development, Wayne, PA
¹⁰Janssen Scientific Affairs, LLC, Horsham, PA
¹¹Legend Biotech USA, Piscataway, NJ
¹²Univiersity College London Cancer Institute, London, United Kingdom

Karen Sweiss, PharmD¹, Pritesh Patel², Janet Guo^3*, Kyeongmin Kim^3*, Jordan M Schecter⁴, Christina Y Sheng^5*, Dawei Song^4*, Xiaoying Xu^4*, Yaming Su^4*, Weirong Wang^4*, Deepu Madduri, MD^4*, Carolyn C Jackson^4*, Enrique Zudaire⁶, Tzu-min Yeh^4*, Tito Roccia^7*, Dong Geng^8*, Lida Pacaud^8*, Douglas W Sborov^9*, Mitch A Phelps^3* and Craig C Hofmeister, MD¹⁰

¹Department of Pharmacy Practice, University of Illinois at Chicago, Hinsdale, IL
²Division of Hematology and Oncology, University of Illinois at Chicago, Chicago, IL
³Division of Pharmaceutics and Pharmacology, College of Pharmacy, Comprehensive Cancer Center, The Ohio State University, Columbus, OH
⁴Janssen Research & Development, Raritan, NJ
⁵Janssen Research & Development; Georgia Institute of Technology; Emory University, Raritan, NJ
⁶Janssen Research & Development, Spring House, PA
⁷Janssen Global Services, Raritan, NJ
⁸Legend Biotech USA, Piscataway, NJ
⁹University of Utah Huntsman Cancer Institute, Salt Lake City, UT
¹⁰Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA

Hongying You, MD^1*, Hongjie Shen, MD, PhD^2*, Song Jin, MD, PhD^1*, Qingqing Wang, MD^1*, Shuang Yan, MD^1*, Yingying Zhai, MD^1*, Weiqin Yao, MD^1*, Xiaolan Shi, MD, PhD^1*, Jingjing Shang, MD, PhD^1*, Lingzhi Yan, MD, PhD^2*, Ying Yao, MD^3*, Jing Wang, MD^3*, Panfeng Wang, MD^3*, Jinlan Pan, MD^1*, Depei Wu¹ and Chengcheng Fu, MD, PhD^1*

¹National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China
²Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, NHC Key Laboratory of Thrombosis and Hemostasis, The First Affiliated Hospital of Soochow University, Suzhou, China
³Soochow Hopes Hematonosis Hospital, Suzhou, China

Katie Dunphy^1*, Despina Bazou, BSc, MSc, PhD^2*, Paul Dowling, BSc, PhD^1* and Peter O'Gorman, MD, PhD, FRCP, FRCPath²

¹Biology Department, Maynooth University, Co. Kildare, Ireland
²Department of Hematology, Mater Misericordiae University Hospital, Dublin 7, Ireland

Julia Catini, PharmD, MBA^1*, Quan Doan, PharmD^2*, Jennifer Evans, DVM, MPH^1*, Andrew Rava^3*, Thomas Defay, PhD^1*, Guillermo Del Angel, PhD^4*, Megan Teynor, ScD^1*, Candida Cristina Quarta, MD^1*, Mathew S. Maurer, MD^5* and Isabelle Lousada, MA^6*

¹Alexion, AstraZeneca Rare Disease, Boston, MA
²Genesis Research LLC, Hoboken, NJ
³Genesis Research, Hoboken
⁴Alexion Pharmaceuticals Inc., Boston, MA
⁵Division of Cardiology, Columbia University, New York, NY
⁶Amyloidosis Research Consortium, Inc., Newton, MA

David M. Cordas dos Santos^1,2,3*, Paul Trinkner^1,2*, Sophie Guenther^1,2*, Michael Winkelmann, MD^4*, Wolfgang G. Kunz, MD^4*, Kai Rejeski, MD^1,3,5, Marion Subklewe, MD^6,7,8, Michael von Bergwelt, Prof. Dr.^1,3,9* and Sebastian Theurich, MD^1,2,3*

¹Department of Medicine III, University Hospital, LMU Munich, Munich, Germany
²Cancer and Immunometabolism Research Group, Gene Center, LMU Munich, Munich, Germany
³German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner Site Munich, Heidelberg, Germany
⁴Department of Radiology, University Hospital, LMU Munich, Munich, Germany
⁵Laboratory for Translational Cancer Immunology, Gene Center, LMU, Munich, Germany
⁶German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany
⁷Department of Medicine III (Hematology/Oncology), LMU University Hospital Munich, Muenchen, Germany
⁸Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany
⁹Comprehensive Cancer Center (CCC), LMU Munich, Munich, Germany

Evangelos Terpos, MD, PhD¹, Margherita Rosati, PhD^2*, Jenifer Bear, PhD^3*, Robert Burns, PhD^3*, Ioannis Ntanasis-Stathopoulos, MD^1*, Santhi Devasundaram, PhD^3*, Maria Gavriatopoulou, MD^1*, Efstathios Kastritis, MD^1*, Meletios-Athanasios Dimopoulos, MD, PhD¹, George N Pavlakis, MD, PhD^2* and Barbara K Felber, PhD^3*

¹Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
²Human Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick
³Human Retrovirus Pathogenesis Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute at Frederick, Frederick

Sanjay de Mel, MBBS^1*, Jonathan Adam Scolnick, PhD^2*, Chern Han Yong, PhD^3*, Stacy Xu, MS^2*, Cinnie Yentia Soekojo, MD⁴, Fangfang Song^5*, Melissa Ooi, MB BCh, BAO, MRCP(I), FRCPath, PhD^6* and Wee Joo Chng, MBChB PhD^6,7

¹National University Cancer Institute, Kent Ridge, Singapore
²Singleron Biotechnologies, Singapore, Singapore
³School of Computing, National University of Singapore, Singapore, Singapore
⁴Department of Haematology Oncology, National University Cancer Institute, Singapore, National University Health System, Singapore, Singapore
⁵National University Cancer Institute, National University Health System, Singapore, Singapore
⁶National University Cancer Institute, Singapore, Singapore
⁷Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

Joshua Richter, MD¹, Peter Feng Wang, PhD, MPH, BSM^2*, Alexa Molinari, PharmD^2,3*, Boris Gorsh, PharmD^2*, Natalie Boytsov, PhD^2*, Suzanne Landi, PhD^2*, Sue Perera, PhD^4*, Prani Paka, PharmD^2*, Teresa Palumbo, MPAS, PA-C^2*, Mei Sheng Duh, ScD, MPH⁵, Christopher Yee, MSc^5*, Anamika Khanal, BA^5*, Sonia Gupta, MS^5* and Ajai Chari, MD⁶

¹Mount Sinai School of Medicine, New York, NY
²GSK, Upper Providence, PA
³Rutgers Center for Health Outcomes, Policy, and Economics, Rutgers, The State University of New Jersey, Piscataway, NJ
⁴GSK, London, United Kingdom
⁵Analysis Group, Inc., Boston, MA
⁶Icahn School of Medicine at Mount Sinai, New York City, NY

Luis Gerardo Rodríguez-Lobato, MD, PhD^*, Anna de Daniel i Bisbe, MD^*, Natalia Tovar, MD, PhD^*, Raquel Jiménez-Segura, MD^*, M. Teresa Cibeira, MD, PhD^*, David F. Moreno, MD^*, Aina Oliver-Caldes, MD^*, Alexandra Martínez-Roca, MD^*, Ester Lozano, PhD^*, Joan Bladé Creixenti, MD, PhD, Laura Rosinol Dachs^* and Carlos Fernandez de Larrea, MD

Amyloidosis and Myeloma Unit, Hospital Clínic, Barcelona, Institut d’Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain

Dipanjan Debnath, MBBS¹, Valentina Baez Sosa, MD² and Joseph P. Catlett, MD³

¹MedStar Georgetown University/Washington Hospital Center, Washington, DC
²Transfusion Medicine and Center for Cellular Engineering, National Institutes of Health, Bethesda, MD
³Department of Hematology, Washington Hospital Center, Washington, DC

Maggie Wong, MBBS, MRCP^1*, Chen Wang, MD^2*, Cinnie Yentia Soekojo, MD³, Hung Chew Wong^4*, Sanjay De Mel, BSc, FRCPath, MRCP^5*, Melissa Ooi, MB Bch, BAO, MRCP(I), FRCPath, PhD^3*, Miny Samuel, PhD^6*, Yu Yang Soon^7* and Wee Joo Chng, MBChB PhD⁸

¹Haematology, National University Cancer Institute, Singapore, Singapore, Singapore
²Department of Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL
³Department of Haematology Oncology, National University Cancer Institute, Singapore, National University Health System, Singapore, Singapore
⁴National University Singapore, Singapore, Singapore
⁵Department of Haematology-Oncology, National University Health System, Singapore, Singapore
⁶Research Support Unit, National University of Singapore, Singapore, Singapore
⁷Department of Radiation Oncology, National University Cancer Institute, Singapore, National University Health System, Singapore, Singapore
⁸National University Cancer Institute, Singapore, Singapore

Qinyu Liu, MD^1*, Hongbin Yu^2* and Yu Wu, MD³

¹Department of Hematology and Hematology Research Laboratory, West China Hospital, Sichuan University, Chengdu, Sichuan, China
²Department of Hematology and Hematology Research Laboratory, West China Hospital, Sichuan Universtiy, Chengdu, China
³Department of Hematology and Hematology Research Laboratory, West China Hospital, Sichuan University, Chengdu, China

Rajshekhar Chakraborty, MBBS¹, Rachael Sexton, BS^2*, Suzanne Lentzsch, MD, PhD³, Muneer H. Abidi, MD⁴, Peter M. Voorhees, MD⁵, Adam D Cohen, MD⁶, Eric Rohren^7*, Stephen B. Heitner, MD^8*, Kevin R. Kelly, MD, PhD^9*, Niklas J Mackler, MD^10*, David M. Baer, MD¹¹, Antje Hoering, PhD¹², Brian G.M. Durie, MD¹³, Sikander Ailawadhi¹⁴ and Robert Z. Orlowski, MD, PhD¹⁵

¹Hematology and Oncology, Columbia University Medical Center, New York, NY
²Cancer Research And Biostatistics, Seattle, WA
³Department of Medicine, Division of Hematology/Oncology, Columbia University Irving Medical Center, New York, NY
⁴Michigan State University/Spectrum Health Cancer Center, Grand Rapids, MI
⁵Plasma Cell Disorders Section, Department of Hematologic Oncology & Blood Disorders, Levine Cancer Center, Charlotte, NC
⁶University of Pennsylvania, Philadelphia, PA
⁷Baylor College of Medicine, Houston, TX
⁸Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR
⁹Department of Medicine, Division of Hematology, University of Southern California, Los Angeles, CA
¹⁰IHA Ann Arbor Hematology Oncology, Ann Arbor, MI
¹¹Department of Hematology/Oncology, Kaiser Permanente, Oakland, CA
¹²Seattle Cancer Research and Biostatistics, Seattle, WA
¹³Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Outpatient Cancer Center, Los Angeles, CA
¹⁴Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL
¹⁵Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX

Vania T. M. Hungria, MD, PhD¹, Rosane Bittencourt, MD^2*, Gracia Martinez, MD, PhD^3*, Juliana De Andrade Santos, MD^4*, Denise Ramos de Almeida, MD^5*, Vera Lúcia De Piratininga Figueiredo, MD^6*, Danielle Leao Cordeiro De Farias, MD, MSc, MBA⁷, Karla Richter Zanella, MD^8*, Larissa Barchi Muniz, MD^9*, Pedro Carvalho, MD^10*, Juliana Senra, Pharm^10*, Rodrigo Martins Abreu, Pharm, PhD^10* and Éderson Roberto Mattos, MD^11*

¹Clinica São Germano, São Paulo, Brazil
²Hematology Division, Hospital de Clínicas of Porto Alegre (HCPA), Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
³Hospital das Clínicas, Faculdade de Medicina of Universidade de São Paulo, Sao Paulo, Brazil
⁴CEHON – Centro de Hematologia e Oncologia, Salvador, Brazil
⁵Hospital São Vicente de Paulo, Passo Fundo, Brazil
⁶Hospital do Servidor Público de São Paulo, São Paulo, Brazil
⁷Hospital das Clinicas, Universidade Federal de Goiás, Goiânia, Brazil
⁸CEPON - Centro de Pesquisas Oncológicas, Florianópolis, Brazil
⁹Casa de Saúde Santa Marcelina, São Paulo, Brazil
¹⁰Medical Affairs, Takeda Pharmaceuticals Brazil, SÃO PAULO, Brazil
¹¹Centro de Ensino e Pesquisas, Fundação Dr. Amaral Carvalho, Jaú, Brazil

Ashish Patel, MD^1*, Adam C. Smith, PhD^2*, Esther Masih-Khan^1*, Peace Samuel, MSc^1*, Katherine Lajkosz, MSc^3*, Sita Bhella, M.D., MSc^4*, Christine I. Chen, MD¹, Anca Prica, MD, MSc⁴, Donna E. Reece, MD, FRCPC⁵, A. Keith Stewart, MBChB¹, Rodger E Tiedemann, MBChB, PhD¹, Suzanne Trudel¹, Chloe Yang, MD, BS¹ and Vishal Kukreti, MD, FRCP, MSc⁴

¹Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
²Laboratory Medicine Program, University Health Network, Toronto, ON, Canada
³Department of Biostatistics, Princess Margaret Cancer Center, Toronto, ON, Canada
⁴Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada
⁵Princess Margaret Cancer Centre, Toronto, ON, Canada

Lawrence Liu, MD^1*, Mei Wang^2*, Nikhil Grandhi^3*, Mark A. Schroeder, MD^4,5, Theodore S. Thomas, MD, MPHS⁶, Akhil Kumar^2*, Kristin Vargo^2*, Feng Gao, MD, PhD, MPH^7*, Kristen M. Sanfilippo, MD^8,9 and Su-Hsin Chang, PhD^10*

¹City of Hope National Medical Center, Duarte, CA
²Research Service, St. Louis Veterans Affairs Medical Center, St. Louis, MO
³Washington University in St. Louis, Saint Louis, MO
⁴Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO
⁵Siteman Cancer Center, Washington University School of Medicine, Saint Louis, MO
⁶St. Louis Veterans Affairs Medical Center, Saint Louis, MO
⁷Public Health Sciences Division, Washington University School of Medicine, St. Louis, MO
⁸Division of Hematology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO
⁹Department of Medicine, Division of Hematology, Washington University in St. Louis School of Medicine, Chesterfield, MO
¹⁰Research Service, St. Louis Veterans Affairs Medical Center, Saint Louis, MO

Vinit Singh, MD, MBBS¹, Varsha Gupta, MD², Rajshree Gupta, MBBS^3*, Ravneet Bajwa, MD⁴ and Michael J Levitt, MD⁴

¹Internal Medicine, Monmouth Medical Center, Long Branch, NJ
²Department of Hematology and Oncology, Jersey shore university medical center, Neptune, NJ
³JJM Medical College, Rajiv Gandhi University of Health Sciences, Davanagere, India
⁴Hematology Oncology, Jersey Shore University Medical Center, Neptune, NJ

Fengyan Jin, MD, PhD¹, Peiyu Yang, MD^2*, Haimin Chen, MD^3*, Xinyue Liang, MD^2*, Weiling Xu, MD^4*, Shanshan Yu, MD^2*, Wenyang Huang, MD^5*, Xingchen Yi, MS^6*, Qiang Guo, MD^2*, Mengru Tian, MD^2*, Tingting Yue, MD^2*, Mengyao Li, MD^2,7*, Yingjie Zhang, MD^8*, Mengxue Zhang, MD^8*, Yurong Yan, MD^8*, Zhongli Hu, MD^8*, Shaji K Kumar, MD⁹, Fan Zhou, MD^10* and Yun Dai, MD, PhD¹¹

¹Department of Hematology, The First Hospital of Jilin University, Changchun, Jilin, China
²Department of Hematology, The First Hospital of Jilin University, Changchun, China
³Department of Hematology, Shanghai Jing'an District Zhabei Central Hospital, Shanghai, China
⁴Department of Radiology, The First Hospital of Jilin University, Changchun, China
⁵State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences &Peking Union Medical College, Tianjin, China
⁶Laboratory of Cancer Precision Medicine, The First Hospital of Jilin University, Changchun, China
⁷Department of Hematology, Second Hospital of Shanxi Medical University, Taiyuan, China
⁸Department Hematology, The First Hospital of Jilin University, Changchun, China
⁹Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
¹⁰Department of Hematology, Shanghai Jing’an District Zhabei Central Hospital, Shanghai, China
¹¹Laboratory of Cancer Precision Medicine, The First Hospital of Jilin University, Changchun, Jilin, China

Anil Aktas-Samur, PhD^1*, Jill Corre^2*, Laure Buisson^3*, Mariateresa Fulciniti, PhD⁴, Kenneth C. Anderson, MD⁴, Mehmet K. Samur, PhD⁴, Nikhil C Munshi, MD, PhD⁵ and Herve Avet-Loiseau, MD, PhD^6*

¹Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA
²Toulouse, and CRCT, Toulouse, France, Toulouse, France
³Iuct-Oncopole, TOULOUSE, FRA
⁴Dana-Farber Cancer Institute, Boston, MA
⁵Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Boston, MA
⁶Unit for Genomics in Myeloma, Institut Universitaire du Cancer de Toulouse-Oncopole, University Hospital, Toulouse, France

Ariel Kogan Zajdman^1,2*, Adolfo Aleman, MPA^3,4,5*, Bhaskar Upadhyaya, PhD^3,4*, Katherine F. Beach, BA^6,7*, Kseniya Serebryakova, CRC^2,8*, Sarita Agte, MD^3,4*, Katerina Kappes, BSc^3,4*, Charles R. Gleason, BS^7*, Komal Srivastava, MS^6,7*, Oliver Van Oekelen, MD, PhD^3,4, Carlos Cordon-Cardo, MD, PhD^9,10,11*, Florian Krammer, PhD^7,12*, Miriam Merad, MD, PhD^{4,10,13,14,15,16*}, Sundar Jagannath^3,17,18,19, Ania Wajnberg, MD^20,21*, Viviana Simon, MD, PhD^{6,7,22,23,24*} and Samir Parekh, MD^3,4,10,13,25

¹Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA, New York
²Department of Medicine, Hematology, and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA, New York, NY
³Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
⁴Department of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
⁵Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, NY
⁶Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA, New York, NY
⁷Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY
⁸Tisch Cancer Institute at Mount Sinai, New York, NY
⁹Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY
¹⁰Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY
¹¹Department of Pathology, Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, NY
¹²Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY
¹³Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY
¹⁴Department of Oncological Sciences, Tisch Cancer Institute, Mount Sinai School of Medicine, New York, NY
¹⁵Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, Precision Immunology Institute, New York, NY
¹⁶Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, NY
¹⁷Department of Medicine, Hematology and Medical Oncology, Mount Sinai Medical Center, New York, NY
¹⁸Center of Excellence for Multiple Myeloma, Mount Sinai Medical Center, New York, NY
¹⁹Department of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
²⁰Department of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai, New York, NY
²¹Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY
²²Global Health and Emerging Pathogen Institute, Icahn School of Medicine at Mount Sinai, New York, NY
²³Department of Medicine, Division of Infectious Disease, Icahn School of Medicine at Mount Sinai, New York, NY
²⁴Division of Infectious Disease, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA, New York, NY
²⁵Hematology/Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY

Ashima Singh, PhD, MS¹, Aniko Szabo, PhD^2*, Qinghua Lian^3*, Purushottam Laud, MD^3*, Liliana Pezzin^3* and Anita D'Souza, MD, MS^4,5

¹Medical College of Wisconsin, Pewaukee, WI
²Division of Biostatistics, Institute of Health & Equity, Medical College of Wisconsin, Milwaukee, WI
³Medical College of Wisconsin, Milwaukee, WI
⁴Center for International Blood and Marrow Transplant Research, Department of Medicine, The Medical College of Wisconsin Inc., Milwaukee, WI
⁵Division of Hematology/Oncology, Department of Medicine, Froedtert & Medical College of Wisconsin Cancer Center, Milwaukee, WI

Hulya Yilmaz^*, Guldane Cengiz, MD^*, Bulent Karakaya^*, Gul Yavuz^*, Merve Aydogan^*, Sinem Civriz Bozdag, MD^*, Selami Kocak Toprak, MD^*, Meltem Kurt Yuksel, MD^*, Pervin Topçuoğlu, MD^*, Onder Arslan, MD^*, Muhit Ozcan^*, Osman Ilhan^* and Meral Beksac, MD

Department of Hematology, Ankara University Faculty of Medicine, Ankara, Turkey, Ankara, Turkey

Huishou Fan^1,2,3*, Wenqiang Yan^4*, Jingyu Xu^5*, Chenxing Du, MD^6*, Weiwei Sui^7*, Shuhui Deng, MD^8*, Dehui Zou^8*, Lugui Qiu⁹ and Gang An, MD^10*

¹Chinese Academy of Medical Science & Peking Union Medical College, Beijing, China
²National Clinical Research Center for Blood Diseases, Tianjin, China
³Institute of Hematology & Blood Diseases Hospital, Tianjin, Cocos (Keeling) Islands
⁴State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical Colleg, Tianjin, China
⁵State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical Colleg, TianJin, China
⁶State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, TIANJIN, China
⁷State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Blood Diseases Hospital & Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
⁸State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences &Peking Union Medical College, Tianjin, China
⁹Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
¹⁰State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China

Ashok P Pai, MD¹, Lue-Yen S Tucker, BA^2* and David M. Baer, MD¹

¹Hematology Oncology, Kaiser Permanente, Oakland, Oakland, CA
²Division of Research, Kaiser Permanente, Northern California, Oakland, CA

Michael J Slade, MD, MS¹, Abir Khalid, PhD^2*, Mark A Fiala, PhD^3*, Mariya Liyasova, PhD^4*, Mark A Zaydman, MD, PhD^5*, Zac McDonald, PhD^4*, Julie M Fortier, PhD^3*, Sarah Kelley^6*, Zachary D. Crees, MD⁷, Mark A. Schroeder, MD⁸, Keith E Stockerl-Goldstein, MD³, Liqiang Yang, PhD^4* and Ravi Vij, MD, MBBS⁸

¹Department of Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO
²Rapid Novor, Kitchener, ON, Canada
³Department of Medicine, Division of Hematology & Oncology, Washington University School of Medicine, St. Louis, MO
⁴Rapid Novor Inc, Kitchener, ON, Canada
⁵Department of Pathology and Immunology, Division of Laboratory and Genomic Medicine, Washington University School of Medicine, Saint Louis, MO
⁶Washington University School of Medicine, St. Louis, MO
⁷Division of Oncology, Washington University School of Medicine, St. Louis, MO
⁸Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO

Farah Mazahreh, MD^1*, Liyan Mazahreh, MD^2*, Carolina Schinke³, Sharmilan Thanendrarajan, MD³, Maurizio Zangari, MD³, John D Shaughnessy Jr., PhD^4*, Fenghuang Zhan, MD, PhD³, Frits van Rhee⁵ and Samer Al Hadidi, MD, MSc³

¹University of Arkansas for Medical Sciences, Little Rock, AR
²Self, Little rock, AR
³Myeloma Center, Winthrop P. Rockefeller Institute, Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, AR
⁴University of Arkasnas for Medical Sciences, Little Rock, AR
⁵Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR

Aurore Perrot, MD, PhD^1*, Olivier Decaux, MD, PhD^2*, Bruno Royer, MD^3*, Denis Caillot, MD^4*, Karim Belhadj Merzoug, MD^5*, Agathe Farge, MD^6*, Laurent Frenzel, MD, PhD⁷, Cécile Sonntag, MD^8*, Bohrane Slama, MD^9*, Emmanuelle Bourgeois-Petit, MD^10*, Philippe Moreau, MD^11*, Laurent Voillat, MD^12*, Odile Luycx, MD^13*, Lotfi Benboubker, MD^14*, Gian-Matteo Pica, MD^15*, Frederic Maloisel, MD, PhD^16*, Jean-Richard Eveillard, MD^17*, Caroline Algrin, MD^18*, Anna Schmitt, MD^19*, Ronan Garlantézec, MD, PhD^20*, Nathalie Texier^21*, Raphael Germain, MSc^22*, Marion Willaime, MSc^22* and Cyrille Hulin^23*

¹Department of Hematology, Toulouse University Institute of Cancer, Toulouse, France
²Service d'hématologie clinique, Centre Hospitalier Universitaire de Rennes, Rennes, France
³Immuno-Hematology, Saint Louis Hospital, Paris, France
⁴Hématologie clinique, CHU de Dijon, Dijon, France
⁵Unité Hémopathies Lymphoides, CHU Henri Mondor, Creteil, FRA
⁶Service d'hématologie clinique, CHU Caen, Caen, France
⁷Service d'hématologie adulte - Responsable centre régional de traitement de l'hémophilie CRTH - Centre national de référence des mastocytoses CEREMAST, Hôpital Necker - Enfants Malades, Paris, France
⁸Hématologie et Oncologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France
⁹Service d'Oncologie médicale et d'Hématologie clinique, CH d'Avignon, Avignon, France
¹⁰Onco-Hématologie, Hôpital Saint Vincent de Paul – GCS - GHICL, Lille, France
¹¹Hematology Department, University Hospital Hôtel-Dieu, Nantes, France
¹²Hématologie-Oncologie, CH William Morey, Chalons-sur-Saone, France
¹³Hématologie, Hôpital du Scorff, Lorient, France
¹⁴Hématologie Thérapie Cellulaire, CHRU TOURS, Tours, FRA
¹⁵Hématologie Clinique, Centre Hospitalier Métropole Savoie, Chambéry, France
¹⁶Onco-hématologie, Clinique Saint-Anne, Strasbourg, France
¹⁷Hôpital Augustin-Morvan, CHRU de Brest, Brest, France
¹⁸Service Hématologie, UMGEC Institut Daniel Hollard, Grenoble, France
¹⁹Institut Bergonié, Bordeaux, France
²⁰Santé publique et épidémiologie, CHU de Rennes, Université Rennes 1, Rennes, France
²¹Epidémiologie, Kappa Santé, PARIS, France
²²Epidémiologie, Kappa Santé, Paris, France
²³Hôpital Haut Leveque, University Hospital, Pessac, France

Xin Miao^1*, Liviawati S. Wu^2*, Shun Xin Wang Lin^1*, Yan Xu^1*, Yang Chen^1*, Yuki Iwaki^3*, Rachel Kobos⁴, Tara Stephenson^1*, Kristy Kemmerer^1*, Clarissa M. Uhlar^1*, Arnob Banerjee^1*, Jenna D. Goldberg^4*, Danielle Trancucci^4*, Raluca Verona^1*, Lixia Pei^4*, Yaming Su^4*, Daniele Ouellet^1*, Alfred L. Garfall^5*, Amrita Y. Krishnan, MD, FACP⁶, Saad Usmani, MD⁷, Suzette Girgis¹ and Honghui Zhou^1*

¹Janssen Research & Development, Spring House, PA
²Janssen Research & Development, South San Francisco, CA
³Janssen Pharmaceutical KK, Tokyo, Japan
⁴Janssen Research & Development, Raritan, NJ
⁵Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
⁶City of Hope Comprehensive Cancer Center, Duarte, CA
⁷Memorial Sloan Kettering Cancer Center, New York, NY

Beatrice Z Sim, MBBS^1,2*, Anthony Longhitano^2,3*, Jeremy Er, MD^4,5*, Simon J Harrison, MD^2,6,7, Monica Slavin, MBBS FRACP^2,3,7* and Benjamin W Teh^2,3,7*

¹Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
²National Centre for Infections in Cancer, Melbourne, Australia
³Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Australia
⁴Department of Clinical Haematology, Peter MacCallum Cancer Center and Royal Melbourne Hospital, Melbourne, Australia
⁵The Walter and Eliza Hall Institute of Medical Research and Department of Medical Biology, University of Melbourne, Melbourne, VIC, Australia
⁶Clinical Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC, Australia
⁷Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia

Eirini Katodritou, MD^1*, Efstathios Kastritis, MD^2*, Dimitra Dalampira, MD^3*, Sosana Delimpasi, MD^4*, Emmanouil Spanoudakis^5*, Vassiliki Labropoulou^6*, Ioannis Ntanasis-Stathopoulos, MD^7*, Annita Ioanna Gkioka, MD^8*, Nikolaos Giannakoulas, MD^9*, Nikolaos Kanellias, MD^10*, Aggeliki Sevastoudi, MD^3*, Evridiki Michali, MD^11*, Maria Papathanasiou^12*, Maria Kotsopoulou, MD^13*, Anastasia Sioni^14*, Theodora Triantafyllou, MD^3*, Mavra Papadatou^8*, Ioannis V Kostopoulos, PhD^7*, Evgenia Verrou, MD^3*, Meletios-Athanasios Dimopoulos, MD, PhD¹⁵ and Evangelos Terpos, MD, PhD⁷

¹Department of Haematology, Theagenion Anticancer General Hospital, Thessaloniki, Greece
²Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece
³Department of Hematology, Theagenio Cancer Hospital, Thessaloniki, Greece
⁴Department of Hematology, Lymphoma and BMT Unit, EVANGELISMOS HOSPITAL ATHENS GREECE, ATHENS, Greece
⁵Department of Haematology, Democritus University of Thrace Medical School, ALEXANDROUPOLIS, Greece
⁶Dept of Hematology, St Andreas General Hospital of Patras, Patras, Greece
⁷Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
⁸First Department of Propaedeutic Internal Medicine, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece
⁹Department of Hematology, University of Thessaly, University Hospital of Larissa, Larissa, Greece
¹⁰Department of Therapeutics, National and Kapodistrian University of Athens, Alexandra Hospital, Athens, Greece
¹¹Department of Hematology, “G. Gennimatas” General Hospital, Athens, Athens, Greece
¹²Department of Hematology and Bone Marrow Transplantation Unit, G. PAPANICOLAOU HOSPITAL, THESSALONIKI, Greece
¹³Metaxa Cancer Hospital, Piraeus, Greece
¹⁴Dpt of Hematology, St. Savvas Oncology Hospital, Athens, Greece
¹⁵Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

Alessandro Lagana, PhD¹, Santiago Thibaud, MD², David T. Melnekoff, MS^3*, Paula Restrepo, BA^4*, Violetta Leshchenko, PhD^5*, Jonathan McCafferty^6*, Scott Newman, PhD^6*, Abbi Kern^6*, David Corrigan^6*, Feras Hantash, MS, DPhil^6*, Adriana Rossi, MD, MSc⁷, Cesar Rodriguez, MD², Larysa Sanchez, MD², Shambavi Richard, MD⁸, Ajai Chari, MD⁹, Hearn J. Cho, MD, PhD^5,10, Sundar Jagannath¹¹, Joshua Richter, MD¹² and Samir Parekh, MD¹³

¹Department of Oncological Sciences, Icahn School of Medicine At Mount Sinai, New York, NY
²Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
³Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, Brooklyn, NY
⁴Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY
⁵Department of Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
⁶Sema4, Stamford, CT
⁷Icahn School of Medicine, Mount Sinai Hospital, New York, NY
⁸Icahn School of Medicine at Mt Sinai, Hematology/Oncology, Jersey City, NJ
⁹Department of Hematology and Medical Oncology, Tisch Cancer Institute, Mount Sinai School of Medicine, New York, NY
¹⁰Multiple Myeloma Research Foundation, Norwalk, CT
¹¹Department of Medicine, Hematology and Medical Oncology, Mount Sinai Medical Center, New York, NY
¹²Icahn School of Medicine at Mount Sinai, New York, NY
¹³Department of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY